Maravai Lifesciences SEC filings

Filter: All · 8-K · 10-Q · 10-K · Form 4

4Nov. 12, 2026, 4:28 p.m. ETView on SEC.gov
10-QNov. 5, 2026, 4:03 p.m. ETView on SEC.gov
8-KNov. 4, 2026, 4:02 p.m. ETView on SEC.gov
Financial statements and exhibits
AI summary, unreviewedMaravai LifeSciences Q3 2026 revenue rises 10.1% to $45.9 million and full-year revenue and adjusted EBITDA guidance is raised
4Nov. 2, 2026, 8:08 p.m. ETView on SEC.gov
4Oct. 9, 2026, 5:51 p.m. ETView on SEC.gov
4Oct. 1, 2026, 6:02 p.m. ETView on SEC.gov
SCHEDULE 13GSept. 29, 2026, 6:32 p.m. ETView on SEC.gov
4Sept. 9, 2026, 6:49 p.m. ETView on SEC.gov
4Sept. 1, 2026, 6:21 p.m. ETView on SEC.gov
SCHEDULE 13G/AAug. 13, 2026, 4:30 p.m. ETView on SEC.gov
4Aug. 11, 2026, 4:44 p.m. ETView on SEC.gov
10-QAug. 7, 2026, 4:03 p.m. ETView on SEC.gov
8-KAug. 6, 2026, 4:05 p.m. ETView on SEC.gov
Results of operations and financial condition · Financial statements and exhibits
4Aug. 3, 2026, 4:42 p.m. ETView on SEC.gov